Skeletal Dysplasia Account Manager - Boston, MA
BridgeBio
August 20, 2026
Remote friendly (United States)
United States
Sales
What You Will Do
- Drive the launch of Infigratinib (first-in-class therapy for achondroplasia).
- Partner with providers and families with deep clinical acumen and urgency.
Responsibilities
- Develop and execute a territory business plan to meet/exceed sales goals.
- Demonstrate expertise in Infigratinib, achondroplasia, and skeletal dysplasia; conduct clinically relevant, compliant discussions.
- Use sales/target data to identify growth opportunities and address territory challenges.
- Anticipate business challenges, adjust priorities, and develop solutions.
- Partner compliantly with Field Medical Directors, Field Reimbursement Managers, Family Account Managers, and the HUB to maximize customer/family satisfaction.
- Build relationships with KOLs with Marketing and Medical Affairs to expand advocacy.
- Operate with an “One Bridge” mindset; collaborate across the organization with integrity.
- Maintain high proficiency in selling skills, clinical/market/product knowledge, and territory business environment.
- Ensure all activities comply with applicable regulations, company policies, and Pharma guidelines.
Critical Capabilities
- Business acumen/results orientation; analytical skills for market opportunities.
- Resilience and confidence (“hunter’s mentality”).
- Build trusting relationships; continuously deepen clinical knowledge (learning agility).
- Influence multidisciplinary care teams; coordinate with Regional Sales Director and cross-functional partners for launch.
Who You Are (Qualifications)
- 8–10 years pharma/biotech; 4+ years rare disease/genetic/skeletal dysplasia (achondroplasia/pediatric rare disease preferred).
- BS/BA required; MBA a plus.
- Extensive travel.
- Product/indication launch experience; account management success.
- Strong communication/influence, accountability, judgment, organization.
- AI fluency.
- Integrity and commitment to ethical/compliance culture.
- Drive the launch of Infigratinib (first-in-class therapy for achondroplasia).
- Partner with providers and families with deep clinical acumen and urgency.
Responsibilities
- Develop and execute a territory business plan to meet/exceed sales goals.
- Demonstrate expertise in Infigratinib, achondroplasia, and skeletal dysplasia; conduct clinically relevant, compliant discussions.
- Use sales/target data to identify growth opportunities and address territory challenges.
- Anticipate business challenges, adjust priorities, and develop solutions.
- Partner compliantly with Field Medical Directors, Field Reimbursement Managers, Family Account Managers, and the HUB to maximize customer/family satisfaction.
- Build relationships with KOLs with Marketing and Medical Affairs to expand advocacy.
- Operate with an “One Bridge” mindset; collaborate across the organization with integrity.
- Maintain high proficiency in selling skills, clinical/market/product knowledge, and territory business environment.
- Ensure all activities comply with applicable regulations, company policies, and Pharma guidelines.
Critical Capabilities
- Business acumen/results orientation; analytical skills for market opportunities.
- Resilience and confidence (“hunter’s mentality”).
- Build trusting relationships; continuously deepen clinical knowledge (learning agility).
- Influence multidisciplinary care teams; coordinate with Regional Sales Director and cross-functional partners for launch.
Who You Are (Qualifications)
- 8–10 years pharma/biotech; 4+ years rare disease/genetic/skeletal dysplasia (achondroplasia/pediatric rare disease preferred).
- BS/BA required; MBA a plus.
- Extensive travel.
- Product/indication launch experience; account management success.
- Strong communication/influence, accountability, judgment, organization.
- AI fluency.
- Integrity and commitment to ethical/compliance culture.